Your session is about to expire
← Back to Search
N/A
Ultrasound-Guided Biopsy for Breast Cancer
N/A
Waitlist Available
Led By Henry Kuerer, MD, PHD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
No Placebo-Only Group
Summary
This trial compares a method using ultrasound to collect cells or tissue from tumors with results from surgery to see if the method can accurately detect disease in patients with tumors.
Who is the study for?
This trial is for adults over 18 with a specific type of breast cancer (either triple negative or HER2 amplified) at various stages. Participants are those who have received preoperative therapy and are planning to undergo surgery.
What is being tested?
The study is examining the effectiveness of using ultrasound-guided biopsy to detect breast cancer compared to traditional surgical methods. It aims to see if this less invasive technique can reliably find evidence of disease.
What are the potential side effects?
Since the intervention being studied is an ultrasound-guided biopsy, potential side effects may include discomfort, bruising, bleeding at the biopsy site, and very rarely infection.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Diagnostic Accuracy of Ultrasound-Guided FNA and Core Biopsy of Initial Breast Cancer Region Compared to Standard Surgery with Pathologic Evaluation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Ultrasound-Guided Biopsy of Tumor SiteExperimental Treatment1 Intervention
Ultrasound-guided biopsy of the tumor site performed before scheduled surgery.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for breast cancer include surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy. Surgery involves the physical removal of the tumor, which is essential for reducing the cancer burden.
Radiation therapy uses high-energy rays to kill cancer cells and shrink tumors, helping to prevent recurrence. Chemotherapy employs drugs to destroy rapidly dividing cancer cells throughout the body.
Hormone therapy blocks hormones like estrogen that fuel certain types of breast cancer, thereby slowing or stopping tumor growth. Targeted therapy focuses on specific molecules involved in cancer cell growth and survival, offering a more precise treatment approach.
These treatments are critical for breast cancer patients as they provide multiple strategies to combat the disease, improve survival rates, and enhance quality of life. Ultrasound-guided biopsy, while not a treatment, is a diagnostic tool that helps in accurately identifying the nature of the breast lesion, guiding appropriate treatment decisions.
Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer.
Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
3,070 Previous Clinical Trials
1,802,765 Total Patients Enrolled
146 Trials studying Breast Cancer
63,160 Patients Enrolled for Breast Cancer
Henry Kuerer, MD, PHDPrincipal InvestigatorM.D. Anderson Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- This criterion is not applicable.You have a specific type of breast cancer and are currently getting treatment before surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Ultrasound-Guided Biopsy of Tumor Site
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.